Shareholders tried to file a securities fraud class action against the biopharmaceutical company in May 2004. The United States District Court for the District of Colorado dismissed the case with prejudice as the plaintiff's complaint failed to meet the legal pleading requirements applicable to its alleged claims. (Oct-21-05)
[PR NEWSWIRE]
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
